1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BARDA Accelerator Network 2. 0 - Supplemental Announcement to Fill Diagnostics and Medical Devices Hub Vacancy is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2.
0).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
#### Looking for contract opportunity help?
* **Contract Opportunity Type:** Solicitation (Updated) * **Updated Published Date:** Apr 06, 2026 01:47 pm EDT * **Original Published Date:**Mar 05, 2026 01:35 pm EST * **Updated Date Offers Due:** Apr 20, 2026 12:00 pm EDT * **Original Date Offers Due:**Apr 20, 2026 12:00 pm EDT * **Inactive Policy:**15 days after date offers due * **Updated Inactive Date:** May 05, 2026 * **Original Inactive Date:**May 05, 2026 * **Original Set Aside:**No Set aside used * **Product Service Code:** AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT * 541714 - Research and Development in Biotechnology (except Nanobiotechnology) * **Place of Performance:**Washington The Office of Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) seeks to establish a partnership to build the next iteration of the Diagnostics/Medical Devices Hub as part of the BARDA Accelerator Network (BAN 2.
0) using BARDA’s Other Transaction Authority (OTA). With BAN 2.
0, BARDA aims to further enhance the global health security innovation ecosystem, optimize startup acceleration and wrap-around services, and ultimately develop an Accelerator Network as a scalable infrastructure for commercialization including active product development support, and validation capabilities during regular operations as well as rapid response during public health emergencies.
Similar to the current BAN Hubs, the Diagnostics/Medical Devices Hub will support BARDA’s mission by addressing the following objectives/tasks, with a focus on innovators and companies that fit within the diagnostics/medical devices space: * Provide wraparound acceleration services, including entrepreneurship education and access to business/commercialization and technical expertise and resources, to BARDA-aligned innovators and companies developing health security solutions.
* Provide BARDA with capabilities to source, review, fund, and accelerate innovators and companies and perform product development, evaluation, and validation of MCMs based on BARDA’s strategic priorities. * Build a rapid emergency response infrastructure to fund and accelerate product development and validation of MCMs that can be developed and deployed as quickly as possible in the event of a public health emergency.
BARDA intends to enter into an Other Transaction Agreement with an organization to provide resources and support for the Diagnostics/Medical Devices focus area: * _Diagnostics/ Medical Devices_ * _Focus on diagnostics and devices to enable pathogen-agnostic surveillance, detection, and diagnosis, especially at point-of-care and at-home settings, and innovative medical devices to improve the quality of casualty care, alert to the potential of an adverse health condition, simplify the collection or processing of testing samples, and protect respiratory health_ The Accelerator Hub can operate independently or as a consortium of partners, though one legal entity must be identified as the prime awardee to enter into an agreement with BARDA.
It is anticipated that the Accelerator Hub will provide funding and/or services to mission-relevant innovators nationally, regardless of the Hub’s physical location. Note: The terms of this announcement supersede all prior announcements/solicitations previously issued as part of the BAN 2. 0 program.
All information contained in those prior versions is replaced in its entirety by this issuance. Interested parties must rely solely on this version, and any subsequent amendments to this version, for terms and conditions pertaining to submission, evaluation,and award. **Submissions are due by 12:00PM ET on April 20, 2026.
Questions are due by 12:00 PM ET on April 2nd, 2026. BARDA may adjust the closing date for submissions through amendment to this notice. ** Additional information is available in the attached solicitation document.
Additionally, please visit https://drive. hhs. gov/.
Edited on 3. 5 to upload updated version of solicitation. Edited on 4.
6 to upload the Q and A document. * O’NEILL HOUSE OFFICE BUILDING * **May 05, 2026 11:55 pm EDT**Solicitation (Updated) * **Apr 06, 2026 01:44 pm EDT**Solicitation (Updated) * **Mar 05, 2026 02:13 pm EST**Solicitation (Updated) * **Mar 05, 2026 01:35 pm EST**Solicitation (Original)
According to the current listing, eligibility includes: Organizations capable of providing resources and support for the Diagnostics/Medical Devices focus area. Confirm the full requirements in the official notice before applying.
BARDA Accelerator Network 2.0 - Supplemental Announcement to Fill Diagnostics and Medical Devices Hub Vacancy is funded by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Broad Agency Announcement for the Advanced Research and Development of Medical Countermeasures (BAA-23-100-SOL-00004) is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. This BAA solicits proposals for the advanced research and development of medical countermeasures (MCMs) such as vaccines, therapeutics, diagnostics, and devices to counter chemical, biological, radiological, and nuclear threats, pandemic influenza, and emerging infectious diseas…
Broad Agency Announcement for the Advanced Research and Development of Medical Countermeasures is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA solicits proposals for the advanced research and development of medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases, including therapeutics for Ebolavirus and Marburgvirus.
BARDA's Programs to Combat Emerging Infectious Diseases is sponsored by Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), HHS. BARDA invests in new approaches and technologies to accelerate the development of vaccines, therapeutic products, and diagnostic tests needed to respond to emerging threats, including Ebola.
NOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read articleOn August 25, 2026 a Ninth Circuit panel affirmed most of a sweeping injunction against HUD, DOT, and HHS grant conditions covering roughly $14 billion. The opinion sorts conditions into four buckets — and only one of them holds up. Here is what changed for every recipient of a federal award.
Read articleUSDA and HHS announced Harvest to Hallways on August 24, 2026: $50M in new cafeteria infrastructure funding on top of $20M in Equipment Assistance Grants, up to $25M more in Patrick Leahy Farm to School awards for FY2026, and $30M in HHS nutrition research. Each pot has a different applicant, a different route, and a different timeline. Here is how to position for all three before the notices post.
Read article